The rs58542926 C>T encoding for the E167K variant in Transmembrane 6 superfamily member 2 (TM6SF2) leads to a decreased expression of the gene and a loss-of-function and increase the risk of NAFLD (Table 1). This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.